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Abstract
Circadian rhythms are regulated at the cellular level by transcriptional feedback loops leading to oscillations in expression of
key proteins including CLOCK, BMAL1, PERIOD (PER), and CRYPTOCHROME (CRY). The CLOCK and BMAL1 proteins are
members of the bHLH class of transcription factors and form a heterodimer that regulates the expression of the PER and CRY
genes. The nuclear receptor REV-ERBa plays a key role in regulation of oscillations in BMAL1 expression by directly binding
to the BMAL1 promoter and suppressing its expression at certain times of day when REV-ERBa expression levels are
elevated. We recently demonstrated that REV-ERBa also regulates the expression of NPAS2, a heterodimer partner of
BMAL1. Here, we show that REV-ERBa also regulates the expression another heterodimer partner of BMAL1, CLOCK. We
identified a REV-ERBa binding site within the 1
st intron of the CLOCK gene using a chromatin immunoprecipitation –
microarray screen. Suppression of REV-ERBa expression resulted in elevated CLOCK mRNA expression consistent with REV-
ERBa’s role as a transcriptional repressor. A REV-ERB response element (RevRE) was identified within this region of the
CLOCK gene and was conserved between humans and mice. Additionally, the CLOCK RevRE conferred REV-ERB
responsiveness to a heterologous reporter gene. Our data suggests that REV-ERBa plays a dual role in regulation of the
activity of the BMAL1/CLOCK heterodimer by regulation of expression of both the BMAL1 and CLOCK genes.
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Introduction
Circadian rhythms play an essential role in coordinating the
timing of various physiological processes. In mammals, the
master clock for circadian rhythm is maintained in the
suprachasmatic nucleus (SCN) in the brain, but many peripheral
organs maintain semi-autonomous clocks that can be set using
signals from the SCN or other signals, such as nutrient status.
The circadian clock is regulated by a transcriptional/translational
feedback loop that involves several key proteins including
circadian locomotor output kaput (CLOCK). CLOCK was initially
discovered in a mutagenesis screen for altered circadian
phenotypes in mice [1]. The CLOCK mutant mice had an
increased period of circadian activity, as determined by wheel
running experiments, and became arrhythmic in constant
darkness. The Clock gene was positionally cloned revealing its
identity as a member of the basic helix-loop-helix family of
transcription factors [2]. Clock is expressed in the SCN of mice as
well as in humans, but also displays a wider pattern of expression
that includes the liver where it may play a role in regulation of
the circadian rhythm in this tissue [3,4,5].
CLOCK functions as a heterodimer with another bHLH
transcription factor, the Brain and Muscle ARNT (Aryl hydro-
carbon receptor nuclear translocator)-like 1 (BMAL1). The
CLOCK/BMAL1 heterodimer binds to E-box elements in the
promoters of the PERIOD (PER) and CRYTOCHROME (CRY)
genes increasing their transcription. The PER and CRY proteins
also heterodimerize and inhibit CLOCK/BMAL1 activity leading
to reduction in PER and CRY expression, thereby completing the
core feedback loop responsible for the circadian rhythm. Two
nuclear receptors that are expressed in a circadian pattern
modulate the activity of this core loop. The retinoic acid
receptor-related orphan receptor a (RORa) and REV-ERBa
directly regulate the expression of BMAL1 by binding to a specific
ROR/REV-ERB response element in the BMAL1 promoter [6].
RORa stimulates BMAL1 whereas REV-ERBa represses tran-
scription. Studies using genetically modified mice show that
RORa and REV-ERBa play a role in maintaining circadian
rhythm. The RORa staggerer mutant mice (RORa
sg/sg) and
RORa
2/2 mice have shortened circadian periods [7]. The REV-
ERBa null mice also have a shortened circadian period and
greater light-induced phase responsiveness [8]. Given that RORa
and REV-ERBa have been shown to regulate BMAL1 expression,
we investigated whether another BMAL1 heterodimer partner,
NPAS2, was regulated by these 2 nuclear receptors and found that
it was a direct target gene [9]. Thus, we next sought to determine if
RORa and/or REV-ERBa might regulate the expression of
CLOCK.
Materials and Methods
ChIP-on-chip
HepG2 cells (ATCC, Manassas, VA) were infected with REV-
ERBa adenovirus and harvested for use in ChIP/microarray as
previously described by our laboratory [9,10,11,12].
Chromatin Immunoprecipitation (ChIP)
HepG2 cells were transfected with 50 nM control or REV-
ERBa siRNA (Dharmacon) using Lipofectamine RNAiMax
(Invitrogen) according to manufacturer’s instructions. Media
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formaldehyde 72 hrs after transfection. The ChIP-IT Express
kit from Active Motif was used. Cells were lysed and then
sonicated to shear the chromatin. Immunoprecipitations were
incubated overnight at 4uC. The ChIP reactions contained
5 mg of the following antibodies: IgG (Active Motif), anti-RNA
Pol II (Active Motif), anti-hREV-ERBa (Cell Signaling), and
anti-hNCoR (Santa Cruz sc-8994). The ChIP reactions were
washed and chromatin was eluted, according to manufacturer’s
instructions. PCR reactions were performed using 50 mLP C R
Supermix High Fidelty (Invitrogen), 1.5 mL of each primer
(10 mM), and 10 mL of eluted chromatin. The IgG and anti-
RNA Pol II were provided in the ChIP-IT human control kit
(Active Motif). The thermocycler program was 94uC for 3 mins;
40 cycles of 94uC for 20 s, 65uC for 30 s, 72uC for 30 s; 72uC
for 2 min. PCR products were visualized using ethidium
bromide gel electrophoresis.
Electrophoretic Mobility Shift Assay (EMSA)
The REV-ERBa coding sequence was excised from p3xFLAG-
REV-ERBa using BamHI and HindIII. The vector pcDNA3.1+
(Invitrogen) was digested with BamHI and HindIII. All fragments
were gel purified, then ligated using T4 DNA Ligase (Promega).
The constructs were verified by sequencing. The constructs
contain a T7 promoter for in vitro transcription and translation
and were used to generate protein for EMSA using the TNT T7
kit (Promega). The putative CLOCK RevRE and the BMAL1
RevRE were annealed and labeled with a
32P dATP using Klenow
polymerase (Promega). Binding reactions contained binding buffer
(Promega), labeled probe, and REV-ERBa protein. The resulting
complexes were loaded onto 5% TBE gels (Biorad) and analyzed
by autoradiography. For competition experiments, unlabled
CLOCK RevRE (wt or mt) was added at 10-, 50- or 100-fold
molar excess. The sequences of the probes utilized in the EMSA
are indicated below:
hCLOCK_ROREwt_F: TTGGAATAAAGTGGGTCACAA-
GGC
hCLOCK_ROREwt_R: TTGCCTTGTGACCCACTTTAT-
TCC
hCLOCK_ROREmut_F: TTGGAATAAAGTGTTTCACAA-
GGC
hCLOCK_ROREmut_R:TTGCCTTGTGAAACACTTTAT-
TCC
hBmalI_ROREwt_F: TTGAAGGCAGAAAGTAGGTCAGG-
GACGGGACGGAG
hBmalI_ROREwt_R: TTCTCCGTCCCTGACCTACTTTC-
TGCCTTC
Cell Culture and Cotransfection Assay
The putative CLOCK RevRE and a mutated RevRE were
synthesized as a three-times repeat (36RevRE) with XhoI and
MluI restriction sites on the ends (IDT). The wild-type and
mutant CLOCK 36RORE oligos were digested with XhoI and
MluI (Promega). The pTL-Luciferase vector was also digested
with XhoI and MluI (Promega). All fragments were gel purified
and ligated using T4 DNA Ligase (Promega). The constructs
were verified by sequencing. The p3x-FLAG-REV-ERBa has
already been described previously [13]. Human HepG2 cells
Figure 1. Identification of a REV-ERBa binding site within the CLOCK gene. (a) Significant REV-ERBa occupancy was observed within the
CLOCK gene within the 1st intron. The genomic structure of CLOCK is shown with REV-ERBa occupancy illustrated as the gray line. The arrow indicates
the direction of transcription. The raw ChIP/chip data is shown in a window beneath the gene as is a screen shot from the integrative genome
browser. (b) The region of REV-ERBa occupancy was scanned for conserved RevRE using the Evolutionarily Conserved Region Browser and
MatInspector. A RevRE was found to be conserved between mice and humans, the alignment of the RevRE is shown. (c) Alignment of the CLOCK
RevRE to a characterized RevRE in the Bmal1 promoter.
doi:10.1371/journal.pone.0017290.g001
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supplemented with 10% fetal bovine serum at 37uC under 5%
CO2. For transfections, HepG2 cells were plated in 96-well plates
at a density of 15610
3 cells/well 24 h prior to transfection.
Transfections were performed using Lipofectamine 2000, ac-
cording to manufacturer’s instructions (Invitrogen). Per well, the
transfection mixture included 50 ng Renilla luciferase as an
internal control, 100 ng of the appropriate CLOCK luciferase
construct, and 100 ng of the p3x-FLAG-REV-ERBa expression
construct. The luciferase activity was measured using the Dual-
Glo luciferase assay system 24 h after transfection (Promega). The
luciferase readings were normalized by well to the Renilla
readings. For treatment with GSK4112, HepG2 cells were plated
into 12-well plates. Cells were then treated with 10 mMG S K 4 1 1 2
or equivalent volume of vehicle. Treatment lasted for 24 hrs.
Cells were harvested for RT-PCR determination of CLOCK
expression.
siRNA Transfection
The siRNAs targeting RORa, RORc, and REV-ERBa were
purchased from Dharmacon (Thermo Fischer). The siRNA was
transfected into HepG2 cells using Lipofectamine RNAiMax,
according to manufacturer’s instructions (Invitrogen). The siRNA-
treated HepG2 cells were incubated for 24 hours before being
harvested for mRNA isolation.
RT-PCR
Extraction of mRNA, synthesis of cDNA, and quantitative PCR
were performed as described previously [14]. The cyclophilin B
(M60857) gene was used as the control. All primers were designed
for human genes. Primer sequences are listed below.
Cyclophilin B forward: 59- GGAGATGGCACAGGAGGAAA -39
Cyclophilin B reverse: 59- CGTAGTGCTTCAGTTTGAA-
GTTCTCA -39
REV-ERBa forward: 59- TTCCGCTTCGGTGGAGCAGC -39
REV-ERBa reverse: 59- CCGGTTCTTCAGCACCAGAG -39
CLOCK forward: 59- TGGGAATCCCTCAACTCAAC -39
CLOCK reverse: 59- GACTGAGGGAAGGTGCTCTG -39
Statistical Analysis
In the co-transfection assays, the values indicated represent the
means 6 S.E. from eight independently transfected wells. In the
RT-PCR assays, the values indicated represent the means 6 S.E.
from four independently transfected wells. The experiments were
repeated at least three times.
Results
A ChIP/chip screen was performed to determine regions where
REV-ERBa is bound within the genome as previously described
[9]. Significant REV-ERBa occupancy was observed with the
Figure 2. REV-ERBa is required for normal expression of CLOCK. HepG2 cells were transfected with siRNAs targeting RORa (78% reduction),
RORc (50% reduction) and REV-ERBa (57% reduction) to reduce their expression. CLOCK expression was then examined by RT-PCR. CLOCK expression
was elevated when REV-ERBa expression was reduced (c), but unaffected by alteration of RORa (a) expression or RORc (b). Data shown is mean 6
SEM where n=4. (d) ChIP assay illustrating REV-ERBa and NCoR occupancy of the 1
st intron of the CLOCK gene. (e) The synthetic REV-ERBa agonist
GSK4112 suppresses CLOCK gene expression in HepG2 cells. *, p,0.05.
doi:10.1371/journal.pone.0017290.g002
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arily Conserved Region Browser [15], it was determined that a
putative RevRE is located within the CLOCK gene that is
conserved between mice and humans, as shown in Figure 1b.
The same site was detected using MatInspector [16]. An
alignment between the CLOCK RevRE site to a characterized
RevRE in the BMAL1 promoter is shown in Figure 1c.
We suppressed RORa (including RORa1 and RORa4),
RORc, and REV-ERBa expression in HepG2 cells by transfecting
the cells with specific siRNAs. When RORa expression was
decreased by ,78% using siRNA, the expression of CLOCK was
unchanged (Figure 2a). A similar lack of effect was observed when
we suppressed RORc expression by ,50% using siRNA
(Figure 2b). However, when REV-ERBa expression was decreased
by ,57% using siRNA, the expression of CLOCK was increased
3.2-fold, as shown in Figure 2c, indicating that endogenous REV-
ERBa exerts a repressive effect on CLOCK expression. We
confirmed occupancy of REV-ERBa at the site identified by the
ChIP-on-chip screen by ChIP and also noted that the corepressor
NCoR was also recruited to the site (Figure 2d). When we
examined occupancy following knock-down of REV-ERBa
expression as indicated above we noticed loss of REV-ERBa
occupancy as well as loss of NCoR occupancy (Figure 2d)
indicating that NCoR recruitment was mediated by REV-ERBa
and consistent with the loss of repressive effects of this receptor and
the increase in CLOCK gene expression we noted in Figure 2c. We
next assessed the ability of a synthetic REV-ERBa agonist to
modulate the expression of CLOCK expression in HepG2 cells.
GSK4112 (SR6452) binds directly to the ligand binding domain of
REV-ERBa and increases the recruitment of NCoR leading to
increased repression of target genes [17,18,19,20]. As shown in
Figure 2e, treatment of the HepG2 cells with GSK4112 results in
repression (,55%) of CLOCK gene expression. Interestingly,
overexpression of REV-ERBa in HepG2 cells did not result in
any change in CLOCK gene expression (data not shown),
suggesting that the endogenous REV-ERBa levels may be
saturating.
The putative RevRE was examined for REV-ERBa binding
using an EMSA. Synthetic oligonucleotides encoding the putative
CLOCK RevRE were radiolabeled, and then incubated with REV-
ERBa protein produced in vitro. The sequences of the oligonucle-
otides are shown in Figure 3a. Direct binding of REV-ERBa to
the wild-type CLOCK RevRE is shown in Figure 3b. Addition of
unlabeled wild-type CLOCK RevRE probe was able to displace the
radiolabeled CLOCK RevRE from REV-ERBa, as shown in
Figure 3b while an excess of unlabeled mutant CLOCK RevRE was
unable to displace the radiolabeled CLOCK RevRE probe from the
REV-ERBa protein demonstrating specificity. We also assessed
the ability of the CLOCK RevRE probe to compete with the well-
characterized BMAL1 RevRE. The BMAL1 RevRE was radiola-
beled and then 100-fold molar excess of unlabeled CLOCK
RevRE was included as a competitor. As illustrated in Figure 3c,
the CLOCK RevRE was able to compete for binding of REV-
ERBa to the BMAL1 RevRE.
Due to the location of the putative RevRE within the 1
st intron
of the CLOCK gene, we generated a three-times repeat of the
RevRE to clone upstream of the firefly luciferase gene (Figure 4a).
When the wild-type 36RevRE reporter construct was transfected
into HepG2 cells, the co-transfection of REV-ERBa suppressed
luciferase expression relative to reporter alone (Figure 4b). The
Figure 3. Identification of a functional RevRE within the CLOCK gene by EMSA. (a) The sequences of the wild-type CLOCK RevRE and mutant
CLOCK RevRE are shown. (b) Demonstration of direct binding of REV-ERBa to radiolabeled CLOCK RevRE DNA. Binding of REV-ERBa to labeled DNA
decreased with addition of unlabeled (cold) CLOCK RevRE, but not mutant CLOCK RevRE. The arrow indicates increases amounts of cold DNA added
(106,5 0 6, and 1006molar excess). (c) EMSA illustrating that REV-ERBa binds to radiolabeled BMAL1 RevRE and that 100-fold molar excess of CLOCK
RevRE DNA can compete for binding to REV-ERBa.
doi:10.1371/journal.pone.0017290.g003
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construct was unaffected by co-transfection of REV-ERBa when
transfected into HepG2 cells. Similar results were observed in
HEK293 cells (data not shown).
Discussion
CLOCK heterodimerizes with BMAL1 and maintains the
circadian expression of target genes containing E-boxes in their
promoters. BMAL1 is a known direct target gene of RORa and
REV-ERBa, whose circadian expression influences the expres-
sion of BMAL1. However, little is known about how the
dimerization partner of BMAL1, CLOCK, is regulated at the
transcriptional level. We recently demonstrated that another
BMAL1 heterodimerization partner, NPAS2, is regulated by
RORa and REV-ERBa providing for a potential mechanism for
coordinated expression of these two bHLH factors that regulate
the circadian rhythm [9]. In this study, we found that another
important factor that heterodimerizes with BMAL1, CLOCK, is
also a target of REV-ERBa. BMAL1 cannot function indepen-
dently of a dimer partner such as CLOCK or NPAS2, thus it is
logical that both components of the heterodimer may share some
regulatory components. Coordination of their regulation by
simultaneous modulation by REV-ERBa may be one mechanism
that this can occur. However, it is intriguing that RORa regulates
BMAL1 expression but does not appear to play a role in
regulation of CLOCK. We also noted that CLOCK is not
responsive to RORc, indicating that this particular response
element in the CLOCK gene is selective for REV-ERBa. Given
the similarity between the BMAL1 and CLOCK RevREs this is
surprising and it is currently unclear what differences may be
driving the selectivity. It is possible that the REV-ERBa
selectivity for regulating the CLOCK gene may be a function of
the HepG2 cell line used in this study and in other cell types
RORa may play a significant role. Alternatively, other BMAL1
partners such as NPAS2 may play a significant role in
maintaining the proper ratio of BMAL1 to heterodimerization
partner. It is interesting to note that in the HepG2 cells we
previously observed circadian oscillations in the expression of
BMAL1, RORa and NPAS2 but not REV-ERBa following a serum
shock [9]. We also observed that CLOCK does not oscillate in the
HepG2 cells (data not shown), which is consistent with the lack of
oscillation in REV-ERBa and the lack of responsiveness to the
oscillating RORa. Again, this pattern of regulation may be specific
for HepG2 cells or in cells or tissues where CLOCK does not
exhibit a strong circadian pattern of expression. Clearly, REV-
ERBa plays an important role in the circadian pattern of
expression of CLOCK in some circumstances since the REV-
ERBa null mouse exhibits a loss in the pattern [8]. Our data
suggests that at least a component of the effect may be mediated
by a direct effect of REV-ERBa on expression of the CLOCK
gene. REV-ERBa mediated regulation of CLOCK adds to the
complexity of the feedback loop that maintains circadian
rhythms. The BMAL1/CLOCK dimer is capable of up-
regulating REV-ERBa, which will then repress BMAL1 and
CLOCK expression. This coordinate regulation of BMAL1 and
Figure 4. Identification of a functional RevRE within the CLOCK gene using reporter-luciferase assays. (a) The reporter constructs contain
a three-times repeat of the putative CLOCK RevRE cloned upstream of the firefly luciferase gene. (b) REV-ERBa was co-transfected with a luciferase
reporter containing the wild-type 36RevRE leading to reduced expression of luciferase relative to the reporter alone. The expression of luciferase
from the mutant 36RORE was unaffected by REV-ERBa co-transfection. Data shown is mean 6 SEM, n=8. *, p,0.05. (c) Proposed model for
coordinated regulation of BMAL1/CLOCK heterodimers.
doi:10.1371/journal.pone.0017290.g004
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oscillations of various genes, including REV-ERBa itself
(Figure 4c).
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